Header Logo

Oren Schaefer

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonia
2
2005
295
0.200
Why?
Suppuration
1
2003
11
0.200
Why?
Mycobacterium avium Complex
1
2003
3
0.200
Why?
Mycobacterium avium-intracellulare Infection
1
2003
8
0.200
Why?
Respiratory Tract Infections
1
2003
90
0.180
Why?
Bacterial Infections
1
2003
151
0.170
Why?
Cough
1
2003
183
0.170
Why?
Complement C1 Inhibitor Protein
1
2010
1
0.080
Why?
Angioedemas, Hereditary
1
2010
1
0.080
Why?
Complement Inactivating Agents
1
2010
15
0.080
Why?
Severity of Illness Index
2
2005
1572
0.070
Why?
Mianserin
1
2005
3
0.060
Why?
Oxazolidinones
1
2005
16
0.060
Why?
Serotonin Syndrome
1
2005
9
0.060
Why?
Citalopram
1
2005
22
0.060
Why?
Acetamides
1
2005
17
0.060
Why?
Urticaria
1
2004
6
0.050
Why?
Cold Temperature
1
2004
53
0.050
Why?
Antidepressive Agents
1
2005
244
0.050
Why?
Triage
1
2005
137
0.050
Why?
Hypothermia, Induced
1
2004
49
0.050
Why?
Patient Admission
1
2005
200
0.050
Why?
Immunocompetence
1
2003
21
0.050
Why?
Bronchoscopy
1
2003
88
0.050
Why?
Aortic Valve
1
2004
181
0.040
Why?
Coronary Artery Bypass
1
2004
292
0.040
Why?
Intensive Care Units
1
2005
437
0.040
Why?
Heart Valve Prosthesis Implantation
1
2004
171
0.040
Why?
Radiography
1
2003
559
0.040
Why?
Diagnosis, Differential
1
2003
993
0.040
Why?
Chronic Disease
1
2003
745
0.040
Why?
Anti-Bacterial Agents
1
2005
809
0.040
Why?
Middle Aged
4
2005
18526
0.040
Why?
Female
5
2010
34470
0.030
Why?
Adult
3
2010
17601
0.020
Why?
Aged
3
2005
15161
0.020
Why?
Humans
6
2010
65883
0.020
Why?
Adolescent
1
2003
6372
0.020
Why?
Male
4
2010
31446
0.020
Why?
Retrospective Studies
1
2003
6961
0.020
Why?
Ultrafiltration
1
2010
10
0.020
Why?
Cross-Over Studies
1
2010
163
0.020
Why?
Infusions, Intravenous
1
2010
193
0.020
Why?
Nanotechnology
1
2010
139
0.020
Why?
Analysis of Variance
1
2010
606
0.020
Why?
Acute Disease
1
2010
665
0.020
Why?
Double-Blind Method
1
2010
749
0.020
Why?
Proportional Hazards Models
1
2010
746
0.020
Why?
Linezolid
1
2005
7
0.010
Why?
Protein Synthesis Inhibitors
1
2005
23
0.010
Why?
Drug Synergism
1
2005
142
0.010
Why?
Bone Marrow Transplantation
1
2005
140
0.010
Why?
Transplantation, Homologous
1
2005
250
0.010
Why?
Urinary Tract Infections
1
2005
97
0.010
Why?
Community-Acquired Infections
1
2005
95
0.010
Why?
Rewarming
1
2004
6
0.010
Why?
Leukemia, Myeloid, Acute
1
2005
193
0.010
Why?
Sensitivity and Specificity
1
2005
1172
0.010
Why?
Pilot Projects
1
2005
1030
0.010
Why?
Child
1
2010
4656
0.010
Why?
Risk Assessment
1
2005
2116
0.010
Why?
Aged, 80 and over
1
2005
5685
0.010
Why?
United States
1
2005
8192
0.010
Why?
Schaefer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_